Continental Breakfast

8:00 am – 8:30 am
Continental Breakfast in the Exhibit Hall

Welcome

8:30 am – 8:35 am
Opening Remarks

Side Effects: Different Tumor Types, Different Experiences

Moderators: Sanjiv S. Agarwala, MD; Edward S. Kim, MD, FACP; David L. Porter, MD
8:35 am – 9:30 am
Participate in a lively, rapid-fire discussion coupled with audience Q&A. A multidisciplinary panel will review the different experiences a patient might face based on tumor type, treatment option and long-term effects. Different symptoms and tests will be presented and analyzed in a very clinical and practical manner that the audience can interpret and use in everyday practice.
Panelists: Michael R. Bishop, MD; Philip D. Bonomi, MD; Melissa L. Johnson, MD; Nikhil I. Khushalani, MD; Steven J. O’Day, MD; Nirav N. Shah, MD, MSHP

Exhibit Hall Break

9:30 am – 9:50 am
Refreshments and Networking in the Exhibit Hall

The Great Debates

Moderators: Sanjiv S. Agarwala, MD; Edward S. Kim, MD, FACP; David L. Porter, MD
9:50 am – 9:53 am
Pretest
9:54 am – 10:14 am
Is There Still a Role for Chemotherapy in Lung Cancer Treatment: Chemotherapy Plus IO vs. IO Alone
Chemotherapy Plus IO: Philip D. Bonomi, MD
IO Alone: Melissa L. Johnson, MD
10:15 am – 10:20 am
Discussion
10:21 am – 10:41 am
CAR T Cells vs. Autologous SCT for Relapsed DLBCL
CAR T Cells: Michael R. Bishop, MD
Autologous SCT: Nirav N. Shah, MD, MSHP
10:42 am – 10:47 am
Discussion
10:48 am – 11:08 pm
Targeted Therapy First vs. Immunotherapy First for the BRAF-positive Patient?
Targeted Therapy First: Nikhil I. Khushalani, MD
Immunotherapy First: Steven J. O’Day, MD
11:09 pm – 11:14 pm
Discussion
11:15 am – 11:17 am
Posttest

Practical Points: What Will You Do on Monday?

Moderators: Sanjiv S. Agarwala, MD; Edward S. Kim, MD, FACP; David L. Porter, MD
11:17 am – 12:15 pm
The meeting concludes with highlights of key pearls from the weekend as we put it all together from a comprehensive perspective. This will be a highly interactive and dynamic discussion to make sure attendees take away ready-to-use applications of real-world data: How it will change the way you practice and how it will change the way patients are treated.